Search
Showing results for "1"
Parents of young children with type 1 diabetes experience significantly better quality of life and reduced fear of hypoglycaemic episodes when given remote access to their child's continuous glucose monitoring, new Children's Diabetes Centre research has found.
Oliver Bowman is too young to understand the enormity of having type 1 diabetes but his young parents Brooke and Aidan know all too well the reality of having a child with a chronic disease.
Children with type 1 diabetes using an insulin pump have better glycaemic control than to those using multiple daily injections (MDI) of insulin, a new Children's Diabetes Centre study has found.
If your child/adolescent has been approved to use CGM but decides they do not want to use it, it is important to complete a NDSS change/termination form, which needs to be returned to your clinic team.
The school holidays and Christmas are a welcome break for most families but the lack of routine can prove a trying time for families living with Type 1 Diabetes
Following last year's World Rett Syndrome Congress held in New Orleans, the 3rd European Rett Syndrome Conference was held in the Netherlands over 3 days.
The aim of the study is the early identification of problems with the current flu vaccines, and providing parents and professionals with up to date information.
The CMVictory Study aims to learn more about the safety and effectiveness of a potential CMV vaccine.
Early detection of cerebral palsy (CP) risk is possible from 12 weeks corrected gestational age (CGA) using standardised assessments; however, up to half of children at risk are not referred early, missing out on early intervention. We investigated the barriers and facilitators to accessing early intervention from the perspective of parents of children who did not receive services by 6 months CGA.
Cytokines of the TGF-β superfamily control essential cell fate decisions via receptor regulated SMAD (R-SMAD) transcription factors. Ligand-induced R-SMAD phosphorylation in the cytosol triggers their activation and nuclear accumulation. We determine how R-SMADs are inactivated by dephosphorylation in the cell nucleus to counteract signaling by TGF-β superfamily ligands.